LAVA Therapeutics N.V. (LVTX) Tops Q3 EPS by 15c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance